Luis A. Juncos

High Impact

Adjunct Professor of Medicine

University of Arkansas for Medical Sciences

faculty

Luis.Juncos@FreseniusMedicalCare.com

42 h-index 192 pubs 5,555 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Luis A. Juncos's research focuses on kidney diseases, particularly acute kidney injury (AKI) and its management in critical illness and specific patient populations. He has investigated urinary NGAL as a biomarker for AKI in cirrhosis and explored the role of terlipressin in treating hepatorenal syndrome. His work also includes studies on reducing ischemic kidney injury through electrical field modulation to preserve Na+/K+-ATPase function and examining the epidemiology and outcomes of AKI treated with continuous kidney replacement therapy (CRRT).

Juncos has also explored the pathophysiology of AKI in critical illness through narrative reviews and investigated the role of macula densa NOS1β in modulating renal hemodynamics and blood pressure, particularly in the context of gestational hypertension. His research interests extend to drug-induced nephropathies, including the potential role of SGLT2-inhibitors. He leads a research group and maintains an active lab website, demonstrating his engagement in ongoing research.

With a career marked by extensive publication, Juncos has authored 192 publications and accumulated over 5,555 citations, resulting in an h-index of 42. He is recognized as a highly cited researcher. His collaborations include numerous shared publications with researchers at the University of Arkansas for Medical Sciences, such as Nithin Karakala, Joseph H. Holthoff, Michael Connor, and Christian Herzog.

Metrics

  • h-index: 42
  • Publications: 192
  • Citations: 5,555

Selected Publications

  • Guilty or Not Guilty (2026) DOI
  • The Aging Kidney and Acute Kidney Injury (2025) DOI
  • Evaluating Real-World Data of CRRT Dose Prescription: Results from the CRRTnet Registry (2025) DOI
  • NAD+-Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury (2025) DOI
  • Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy (2025) DOI
  • From Receptor to Repair (2025) DOI
  • The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025) DOI
  • ACE2 deficiency protects against heme protein-induced acute kidney injury (2025) DOI
  • The Occurrence of Senescence in the Arteriovenous Fistula in the Rat (2024) DOI
  • Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS) (2023) DOI
  • Nrf2 Activation in the Glomeruli and Podocytes: Deciphering the Renal Mechanisms of Nrf2 (2023) DOI
  • SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023) DOI
  • High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: CON (2023) DOI
  • Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study (2023) DOI
  • Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics